Search is Powered by Google
Pharma Industry / Biotech Industry News

Alps Bio Cluster - Development Of The First European Transalpine Biotech And Medtech Network

Main Category: Pharma Industry / Biotech Industry
Article Date: 20 Nov 2008 - 1:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Six transalpine regions, representing five European countries, have just formalized the creation of the Alps Bio Cluster, a European cluster initiative that aims to unite research, industrial and training resources in the biotech and medtech sectors over an extended transalpine area.

The following countries and regions are involved in the new cluster:

-- France - Rhône-Alpes region
Active partners: ADEBAG (project coordinator); LyonBiopôle

-- Italy - Lombardia and Piemonte regions
Active partners: Bioindustry Park del Canavese SpA; Milan Chamber of Commerce

-- Switzerland - Western Switzerland region
Active partner: BioAlps

-- Austria - Tyrol region
Active partner: Tiroler Zukunftsstiftung (Tyrolean future foundation)

-- Germany - Bavaria and Upper Bavaria regions
Active partners: Helmholtz-Zentrum München (German Research Centre for Environmental Health), Weihenstephan University of Applied Sciences (Faculty of Biotechnology and Bioinformatics)

This rapprochement has emerged from the various partners' desire to develop appropriate and effective methods of cooperation in order to serve a highly competitive sector that has great potential for economic development over the entire area concerned.

The aim is to create the necessary conditions to support the development of SMEs at European and international level by stimulating innovation by means of cooperation within the transnational Alpine area.

The Alps Bio Cluster will be co-funded by the European Commission, at a 76% rate for three years (2008 - 2011). The total budget of the project is € 1 862 505. During three year, the partners will encourage transalpine cooperation between R&D centres, universities, start-ups and SMEs by creating thematic networks uniting resources from academic, industrial and training environments. This cooperation will therefore take on a dual transnational and "trans-sectorial" dimension.

The main working slogan is "a healthy life at home in the Alps in a natural environment worthy of preservation" and two networks will be developed:

1. Autonomy and healthcare
2. New diagnosis and therapies

There are two key focuses to the work undertaken. Firstly, the use of new information and communication technologies in the medical sector in order to guarantee improved access to healthcare, this subject being of particular relevance in the Alps where accessibility is a fundamental concern.

Secondly, environmental health problems, where "green biotechnologies" related to the environment meet "red biotechnologies" that focus on healthcare applications.

Events will be planned surrounding these subjects during the entire three-year period in the various regions involved.

In the meantime, the first major step for the cluster involves the creation of a joint competitive identity enabling the "Alpine brand" to be promoted in the biotech and medtech sectors both within and outside the Alpine zone.

To strengthen the position occupied by the Alps Bio Cluster, a territorial survey will be carried out to analyze the strengths and weaknesses of each region, the partners involved and the key players in the sectors concerned. This regional survey will be reinforced by a transnational territorial analysis. This should enable the partners involved to adopt a clear and relevant stance.

And let us not forget that the French, Italian and Swiss partners have already been active within the BioAlpine Cluster for two years now. Extending their cooperation to other European countries represents an important part of the approach and the dynamic of this cluster.

Source
Valerie Ayache
Director of Grenoble Alpes Bio Network
http://www.adebag.org





Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Urology
ADHD Autism Diabetes

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster And Better Symptom Control Than Concerta(R)1 In Early Part Of ADHD Patients' Day
09 Jul 2008
A head-to-head study, published in the June Journal of Child and Adolescent Psychopharmacology, confirms that Focalin(R) XR (dexmethylphenidate HCl) extended-release capsules offer greater improvements in managing...


LASIK Surgery - Trading in Lenses for Laser
LASIK Surgery - Trading in Lenses for Laser

For millions of Americans, LASIK ends years of dependence on glasses and contact lenses. But there are risks, and the surgical procedure is not for everyone.

more videos are available in our health videos section.